Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. scores highest on Torque (94) and lowest on Price (0). Its PosiPenta is 37.76 out of 100, weaker than most similar companies.
On the Penta Grid this week, Foghorn Therapeutics Inc. is Grid #611 of 837 in the Healthcare sector in United States, and Grid #3,085 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 37.76 | 0 | 36 | 20 | 94 | 39 |
| Black Diamond Therapeutics, Inc. | 35.22 | 39 | 34 | 28 | 50 | 24 |
| Owlet, Inc. | 35.91 | 21 | 74 | 11 | 32 | 42 |
| Definitive Healthcare Corp. | 41.42 | 43 | 60 | 36 | 28 | 39 |
| Humacyte, Inc. | 29.23 | 17 | 60 | 26 | 8 | 35 |
| Voyager Therapeutics, Inc. | 38.74 | 43 | 39 | 19 | 44 | 49 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.89 |
| P/B ratio | -1.36 |
EEarnings
| Trailing EPS | ₹-92.82 |
| Forward EPS | ₹-97.20 |
NNitro
| Price | 175.22 |
| 52-week high | 720.78 |
| 52-week low | 169.54 |
| Fall from 52-week high | 75.7% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.38 |
AAnchor
| Beta (price swings) | 3.01 |
| Market cap | ₹1,040 Cr |
| Insider holding | 14.13% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Foghorn Therapeutics Inc.'s PosiPenta score?
Foghorn Therapeutics Inc.'s PosiPenta is 37.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Foghorn Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Foghorn Therapeutics Inc. is Grid #611 of 837 in the Healthcare sector in United States, and Grid #3,085 of 4,000 in United States.
Which PosiPenta pillar is strongest for Foghorn Therapeutics Inc.?
Torque (durability), with a score of 94 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Foghorn Therapeutics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Foghorn Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 3.17 points, from 34.59 to 37.76.
PositoAI is for research and education only and is not investment advice.